Management Team
Stefano Portolano
Chief Executive Officer and Executive Board Member
Senior commercialization and market access leader
Kyle Landskroner
Head of Preclinical Drug Development
Seasoned expert in early-stage drug discovery & development
Ruben Giorgino
Head of Clinical Research and Development
Well-versed leader in global clinical R&D
Louise Kooij
Head of Finance and Operations
International financial and commercial pharma strategist
Board of Directors
Carlo Incerti
Chairman and Non-Executive Board Member
Operating Partner at Forbion Capital Partners
Vanessa King
Non-Executive Board Member
Venture Partner at Abingworth, LLP
Sander Slootweg
Non-Executive Board Member
Managing Partner at Forbion
Stefano Portolano
Chief Executive Officer and Executive Board Member
Senior commercialization and market access leader
Edward van Wezel
Executive Board Member
Founder and Managing Partner at BioGeneration Ventures
Andreas Wallnöfer
Non-Executive Board Member
General Partner at BioMedPartners